Distinctive barriers to antiretroviral therapy adherence among non-adherent adolescents living with HIV in Botswana

被引:24
|
作者
Yang, Elizabeth [1 ]
Mphele, Seipone [2 ]
Moshashane, Neo [2 ]
Bula, Boineelo [2 ]
Chapman, Jennifer [3 ]
Okatch, Harriet [1 ,4 ]
Pettitt, Ed [5 ,6 ]
Tshume, Ontibile [5 ]
Marukutira, Tafireyi [5 ]
Anabwani, Gabriel [5 ,6 ]
Lowenthal, Elizabeth [3 ,5 ,7 ,8 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Botswana, Dept Psychol, Gaborone, Botswana
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] Univ Botswana, Dept Chem, Gaborone, Botswana
[5] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana
[6] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[7] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[8] Univ Penn, Perelman Sch Med, Dept Epidemiol, Philadelphia, PA 19104 USA
关键词
Outcome expectancy; supervision; treatment fatigue; social support; miscarried helping; TREATMENT FAILURE; CHRONIC PAIN; FAMILIES; OUTCOMES; PARENTS; AFRICA; YOUTH;
D O I
10.1080/09540121.2017.1344767
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Levels of adherence to HIV treatment are lower among adolescents compared with older and younger individuals receiving similar therapies. We purposely sampled the most and least adherent adolescents from a 300-adolescent longitudinal HIV treatment adherence study in Gaborone, Botswana. Multiple objective and subjective measures of adherence were available and study participants were selected based on sustained patterns of either excellent or poor adherence over a one-year period. Focus group discussions (FGD) and in-depth interviews (IDI) were conducted with the adolescents and a subset of their caregivers with the goal of revealing barriers and facilitators of adherence. Focus groups were segregated by adherence classification of the participants. Following coding of transcripts, matrices were developed based on participants' adherence classifications in order to clarify differences in themes generated by individuals with different adherence characteristics. 47 adolescents and 25 adults were included. The non-adherent adolescents were older than the adherent adolescents (median age 18 years (IQR 16-19) vs. 14 years (IQR 12-15 years)), with median time on treatment near 10 years in both groups. Interference with daily activities, concerns about stigma and discrimination, side effects, denial of HIV status, and food insecurity arose as challenges to adherence among both those who were consistently adherent and those who were poorly-adherent to their medications. Low outcome expectancy, treatment fatigue, mental health and substance use problems, and mismatches between desired and received social support were discussed only among poorly adherent adolescents and their caregivers. Challenges raised only among adolescents and caregivers in the non-adherent groups are hypothesis-generating, identifying areas that may have a greater contribution to poor outcomes than challenges faced by both adherent and non-adherent adolescents. The contribution of these factors to poor outcomes should be explored in future studies.
引用
收藏
页码:224 / 231
页数:8
相关论文
共 50 条
  • [41] Work-related Barriers and Facilitators to Antiretroviral Therapy Adherence in Persons Living with HIV Infection
    Torres-Madriz, Gilberto
    Lerner, Debra
    Ruthazer, Robin
    Rogers, William H.
    Wilson, Ira B.
    AIDS AND BEHAVIOR, 2011, 15 (07) : 1475 - 1482
  • [42] Work-related Barriers and Facilitators to Antiretroviral Therapy Adherence in Persons Living with HIV Infection
    Gilberto Torres-Madriz
    Debra Lerner
    Robin Ruthazer
    William H. Rogers
    Ira B. Wilson
    AIDS and Behavior, 2011, 15 : 1475 - 1482
  • [43] Provider perspectives on antiretroviral therapy adherence among psychiatric inpatients in Botswana
    Qambayot, Maria Albin
    Naidoo, Sarita
    AJAR-AFRICAN JOURNAL OF AIDS RESEARCH, 2023, : 123 - 130
  • [44] Substance Use and Adherence to Antiretroviral Therapy among People Living with HIV in the United States
    Przybyla, Sarahmona
    Ashare, Rebecca L.
    Cioffi, Loriann
    Plotnik, Isabella
    Shuter, Jonathan
    Seng, Elizabeth K.
    Weinberger, Andrea H.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (11)
  • [45] Barriers to antiretroviral adherence among HIV-infected adults
    Murphy, DA
    Roberts, KJ
    Martin, DJ
    Marelich, W
    Hoffman, D
    AIDS PATIENT CARE AND STDS, 2000, 14 (01) : 47 - 58
  • [46] Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda
    Nicolette Nabukeera-Barungi
    Peter Elyanu
    Barbara Asire
    Cordelia Katureebe
    Ivan Lukabwe
    Eleanor Namusoke
    Joshua Musinguzi
    Lynn Atuyambe
    Nathan Tumwesigye
    BMC Infectious Diseases, 15
  • [47] Influence of depression and interpersonal support on adherence to antiretroviral therapy among people living with HIV
    Jerry John Nutor
    Akua O. Gyamerah
    Robert Kaba Alhassan
    Henry Ofori Duah
    Rachel G.A. Thompson
    Natalie Wilson
    Orlando Harris
    Jose Gutierrez
    Thomas J. Hoffmann
    Monica Getahun
    Glenn-Milo Santos
    AIDS Research and Therapy, 20
  • [48] Knowledge, Attitude, Practice, and Adherence to Antiretroviral Therapy among People Living with HIV in Nepal
    Shrestha, Sweta
    Chataut, Subodh
    Kc, Badri
    Acharya, Khagendra
    Pradhan, Sait Kumar
    Shrestha, Sunil
    AIDS RESEARCH AND TREATMENT, 2023, 2023
  • [49] Religious belief and uptake of or adherence to antiretroviral therapy among people living with HIV in London
    Tariq, S.
    Ibrahim, F.
    Anderson, J.
    Bukutu, C.
    Cortina-Borja, M.
    Elford, J.
    HIV MEDICINE, 2010, 11 : 47 - 47
  • [50] Influence of depression and interpersonal support on adherence to antiretroviral therapy among people living with HIV
    Nutor, Jerry John
    Gyamerah, Akua O.
    Alhassan, Robert Kaba
    Duah, Henry Ofori
    Thompson, Rachel G. A.
    Wilson, Natalie
    Harris, Orlando
    Gutierrez, Jose
    Hoffmann, Thomas J.
    Getahun, Monica
    Santos, Glenn-Milo
    AIDS RESEARCH AND THERAPY, 2023, 20 (01)